Fedratinib

SL-9449

Fedratinib, >98%

CAS No. : [936091-26-8]

Synonyms : TG-101348; SAR-302503

IUPAC Name : N-(tert-Butyl)-3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Fedratinib is a potent and selective ATP-competitive JAK2 inhibitor, exhibiting IC50 values of 3 nM for both JAK2 and JAK2V617F kinases. It demonstrates 35-fold and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib induces apoptosis in cancer cells and holds significant potential in research focused on myeloproliferative disorders.

References : Wernig G. et al.: Cancer Cell 13(4), 311-20, 2008; Geron I. et al.: Cancer Cell 13(4), 321-30, 2008.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.